Related Experiment Video
Updated: May 10, 2025

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Cerebral microbleeds: prevalence and relationship to clinical features in cognitive impairment with lewy body disease
Zhihong Ren1, Jinghuan Gan2, Zhichao Chen2
1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Background:
The burden of cerebral microbleeds (CMBs) is greater in patients with dementia with Lewy bodies (DLB) than in those with Parkinson disease dementia (PDD), while few studies have been carried out in a large sample size, or focused on the prodromal stage. Thus, we investigated the clinical prevalence of CMBs and its relationship to clinical features in patients with DLB, PDD, mild cognitive impairment with Lewy bodies (MCI-LB) and Parkinson's disease with MCI (PD-MCI) in this study.
Methods:
In this retrospective multicenter cohort study, the study population consisted of 486 patients with DLB, 262 cases with PDD, 74 cases with MCI-LB and 107 cases with PD-MCI from 22 memory clinics between January 2018 and June 2022 in China. Demographic and clinical information were collected by reviewing medical records. CMBs were classified as "present" or "absent" in the Gradient Recalled-Echo or Susceptibility Weighted Imaging.
Results:
The prevalence of CMBs was significantly greater in patients with DLB with 24.69% (95% CI [20.92%, 28.78%]) than patients with PDD with 20.23% (95% CI [5.54%, 25.61%]), patients with MCI-LB with 16.22% (95% CI [8.67%, 26.61%]), and patients with PD-MCI with 12.15% (95% CI [6.63%, 19.88%]). There were sex and age differences in this prevalence. In all patients, the presence of CMBs was significantly and independently associated with the presence of visual hallucination (OR = 1.597, 95% CI [1.014, 2.517], p = 0.044) and fluctuating cognition (OR = 1.707, 95% CI [1.140, 2.556], p = 0.009); and it was associated with the severity of hallucination (B = 0.775, SE = 0.368, p = 0.036) and disinhibition (B = 0.363, SE = 0.148, p = 0.014) reflected by NPI. Moreover, CMBs in DLB were associated with the presence of parkinsonism symptoms (OR = 1.821, 95% CI [1.001, 3.314], p = 0.05), and the scores of UPDRS-III (B = 4.711, SE = 1.939, p = 0.016) and Hoehn-Yahn stage (B = 0.452, SE = 0.165, p = 0.007).
Conclusion:
Patients with DLB had a higher proportion of CMBs than PDD, MCI-LB and PD-MCI. CMBs in all DLB, PDD, MCI-LB and PD-MCI cases were associated with the presence of visual hallucination and fluctuating cognition; in DLB were associated with motor function.
Insights
Cerebral microbleeds (CMBs) are more common in dementia with Lewy bodies (DLB) than in Parkinson disease dementia (PDD) and its prodromal stages. CMBs are linked to visual hallucinations and motor symptoms in DLB patients.
Area of Science:
- Neurology
- Neuroimaging
- Neurodegenerative Diseases
Background:
- Cerebral microbleeds (CMBs) are increasingly recognized in neurodegenerative conditions.
- Their prevalence and clinical significance in dementia with Lewy bodies (DLB) compared to Parkinson disease dementia (PDD) and their prodromal stages remain underexplored in large cohorts.
Purpose of the Study:
- To investigate the prevalence of CMBs in patients with DLB, PDD, mild cognitive impairment with Lewy bodies (MCI-LB), and Parkinson's disease with MCI (PD-MCI).
- To explore the relationship between CMBs and clinical features, including cognitive and motor symptoms, across these Lewy body diseases.
Main Methods:
- A retrospective multicenter cohort study involving 486 DLB, 262 PDD, 74 MCI-LB, and 107 PD-MCI patients.
- Demographic and clinical data were collected from medical records.
- CMBs were identified using Gradient Recalled-Echo or Susceptibility Weighted Imaging.
Main Results:
- CMB prevalence was highest in DLB (24.69%), followed by PDD (20.23%), MCI-LB (16.22%), and PD-MCI (12.15%).
- CMBs were significantly associated with visual hallucinations and fluctuating cognition across all patient groups.
- In DLB patients, CMBs correlated with parkinsonism, UPDRS-III scores, and Hoehn-Yahn stage.
Conclusions:
- Dementia with Lewy bodies exhibits a higher prevalence of cerebral microbleeds compared to Parkinson disease dementia and their mild cognitive impairment stages.
- Cerebral microbleeds are associated with key non-motor symptoms like visual hallucinations and fluctuating cognition in Lewy body diseases.
- Motor function impairments in DLB are linked to the presence of cerebral microbleeds.
More Related Videos
12:28Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
12:50Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014
Related Concept Videos
Dementia
The progression of dementia is generally gradual....
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...